COSCIENS Biopharma Inc. Increase Decrease Through Exercise Of Options
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease Through Exercise Of Options of $13.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-03-25
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2023-12-31 | $13.00K 20-F · filed 2026-03-25 |
| 2022-12-31 | $64.00K 20-F · filed 2025-04-09 |